The Political Economy of the World Health Organization Model Lists of Essential Medicines

The current debate about the role of the WHO EML centers on the question whether the Model Lists ought to include complex, high-priced medicines. However, this research demonstrates that challenges may have roots deeper than amending decision criteria. At the core of this issue is the role of the list. Defining a strategic vision for the WHO EML, refining decision criteria, and increasing institutional support would align interests, good processes, and, ultimately, contribute to positive societal health outcomes.